Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Histiocytic Sarcoma | 2 | 2021 | 41 | 1.420 |
Why?
|
Hodgkin Disease | 8 | 2023 | 1378 | 0.950 |
Why?
|
Oximes | 1 | 2020 | 306 | 0.620 |
Why?
|
Preleukemia | 1 | 2017 | 34 | 0.600 |
Why?
|
Iris Diseases | 1 | 2017 | 37 | 0.590 |
Why?
|
Pyrimidinones | 1 | 2020 | 384 | 0.570 |
Why?
|
Pigmentation Disorders | 1 | 2017 | 105 | 0.570 |
Why?
|
Fetal Macrosomia | 1 | 2017 | 131 | 0.560 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 381 | 0.530 |
Why?
|
Critical Pathways | 1 | 2019 | 475 | 0.500 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2019 | 1547 | 0.490 |
Why?
|
Pyridones | 1 | 2020 | 792 | 0.470 |
Why?
|
Imidazoles | 1 | 2020 | 1180 | 0.450 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2053 | 0.440 |
Why?
|
Sarcoma | 2 | 2021 | 1786 | 0.430 |
Why?
|
Rhabdomyosarcoma, Embryonal | 4 | 2015 | 100 | 0.420 |
Why?
|
Burkitt Lymphoma | 2 | 2013 | 333 | 0.400 |
Why?
|
Neoplasms, Second Primary | 1 | 2020 | 1056 | 0.390 |
Why?
|
Rhabdomyosarcoma | 5 | 2014 | 359 | 0.390 |
Why?
|
Outpatients | 1 | 2019 | 1607 | 0.370 |
Why?
|
Mutation, Missense | 1 | 2020 | 2566 | 0.360 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 16 | 2021 | 11712 | 0.350 |
Why?
|
Inpatients | 1 | 2019 | 2581 | 0.290 |
Why?
|
Lymphatic Diseases | 1 | 2008 | 319 | 0.260 |
Why?
|
Radiotherapy, Conformal | 2 | 2011 | 549 | 0.260 |
Why?
|
Lymphoproliferative Disorders | 2 | 2016 | 533 | 0.260 |
Why?
|
Orbital Neoplasms | 2 | 2005 | 221 | 0.250 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2010 | 491 | 0.240 |
Why?
|
Lymphoma | 3 | 2023 | 1898 | 0.240 |
Why?
|
Irritable Mood | 1 | 2024 | 194 | 0.220 |
Why?
|
Germinoma | 1 | 2003 | 132 | 0.200 |
Why?
|
Child, Preschool | 21 | 2024 | 42063 | 0.200 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3602 | 0.200 |
Why?
|
Mediastinum | 1 | 2003 | 266 | 0.190 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.190 |
Why?
|
Neuroblastoma | 2 | 2024 | 1252 | 0.190 |
Why?
|
Lymphatic Irradiation | 1 | 2021 | 115 | 0.180 |
Why?
|
Medical Order Entry Systems | 1 | 2006 | 522 | 0.180 |
Why?
|
Child | 28 | 2024 | 79806 | 0.170 |
Why?
|
Mediastinal Neoplasms | 1 | 2003 | 402 | 0.170 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2016 | 608 | 0.170 |
Why?
|
Trisomy | 1 | 2021 | 260 | 0.170 |
Why?
|
Herpesvirus 4, Human | 2 | 2021 | 1075 | 0.160 |
Why?
|
Jaundice | 1 | 2019 | 97 | 0.160 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 223 | 0.160 |
Why?
|
Platelet Count | 1 | 2002 | 777 | 0.160 |
Why?
|
Hospitalization | 1 | 2019 | 10790 | 0.160 |
Why?
|
Platelet Transfusion | 1 | 2002 | 294 | 0.160 |
Why?
|
Fever of Unknown Origin | 1 | 2019 | 94 | 0.160 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2021 | 351 | 0.160 |
Why?
|
Disease-Free Survival | 7 | 2021 | 6828 | 0.150 |
Why?
|
Drug Substitution | 1 | 2021 | 296 | 0.150 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2014 | 801 | 0.150 |
Why?
|
Sarcoma, Myeloid | 1 | 2018 | 51 | 0.150 |
Why?
|
Adolescent | 22 | 2024 | 87810 | 0.150 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.140 |
Why?
|
Exophthalmos | 1 | 2018 | 97 | 0.140 |
Why?
|
Sphenoid Bone | 1 | 2018 | 177 | 0.140 |
Why?
|
Infant | 14 | 2024 | 36060 | 0.140 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1998 | 146 | 0.140 |
Why?
|
Lymph Nodes | 4 | 2021 | 3486 | 0.140 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2023 | 1375 | 0.130 |
Why?
|
Blood Cell Count | 3 | 2019 | 397 | 0.130 |
Why?
|
Biopsy | 5 | 2012 | 6771 | 0.130 |
Why?
|
Liver Diseases | 1 | 2024 | 1302 | 0.130 |
Why?
|
Dacryocystitis | 1 | 2016 | 68 | 0.130 |
Why?
|
Meningeal Neoplasms | 3 | 2015 | 1249 | 0.130 |
Why?
|
Gynecomastia | 1 | 2016 | 87 | 0.130 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1737 | 0.130 |
Why?
|
Diagnosis, Differential | 9 | 2024 | 12965 | 0.130 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 935 | 0.120 |
Why?
|
Dyskeratosis Congenita | 1 | 2015 | 73 | 0.120 |
Why?
|
Fever | 3 | 2018 | 1617 | 0.120 |
Why?
|
Male | 38 | 2024 | 359744 | 0.120 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2015 | 58 | 0.120 |
Why?
|
Humans | 49 | 2024 | 760621 | 0.120 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 586 | 0.110 |
Why?
|
Medical Oncology | 1 | 2006 | 2313 | 0.110 |
Why?
|
Combined Modality Therapy | 7 | 2019 | 8552 | 0.110 |
Why?
|
Thrombocytopenia | 1 | 2002 | 1174 | 0.110 |
Why?
|
Radiotherapy Dosage | 6 | 2024 | 2897 | 0.110 |
Why?
|
Immunoglobulin M | 1 | 1998 | 1529 | 0.110 |
Why?
|
Nasal Cavity | 1 | 2015 | 304 | 0.110 |
Why?
|
Medulloblastoma | 1 | 2018 | 679 | 0.110 |
Why?
|
Nose Neoplasms | 1 | 2015 | 249 | 0.110 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2021 | 1596 | 0.100 |
Why?
|
Pancreatic Neoplasms | 1 | 2010 | 5351 | 0.100 |
Why?
|
Pelvic Neoplasms | 1 | 2014 | 248 | 0.100 |
Why?
|
Thoracic Neoplasms | 1 | 2014 | 266 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2058 | 0.100 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2015 | 557 | 0.100 |
Why?
|
Organs at Risk | 2 | 2011 | 358 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2024 | 9276 | 0.090 |
Why?
|
Appendiceal Neoplasms | 1 | 2013 | 155 | 0.090 |
Why?
|
Whole Body Imaging | 1 | 2012 | 278 | 0.090 |
Why?
|
Neoplasms | 4 | 2023 | 22072 | 0.090 |
Why?
|
Liver Transplantation | 1 | 2002 | 2325 | 0.090 |
Why?
|
Melanoma | 2 | 2019 | 5697 | 0.090 |
Why?
|
Autoantibodies | 1 | 1998 | 2118 | 0.080 |
Why?
|
Hemorrhage | 1 | 2002 | 3600 | 0.080 |
Why?
|
Fractures, Compression | 1 | 2011 | 129 | 0.080 |
Why?
|
Skin Neoplasms | 2 | 2019 | 5799 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1919 | 0.080 |
Why?
|
Female | 26 | 2024 | 391270 | 0.080 |
Why?
|
Crohn Disease | 1 | 2021 | 2275 | 0.080 |
Why?
|
Hypercalcemia | 1 | 2011 | 421 | 0.080 |
Why?
|
Doxorubicin | 4 | 2015 | 2209 | 0.080 |
Why?
|
Lumbar Vertebrae | 2 | 2011 | 1868 | 0.070 |
Why?
|
Lymphadenitis | 1 | 2008 | 98 | 0.070 |
Why?
|
Breast | 1 | 2016 | 1963 | 0.070 |
Why?
|
Treatment Outcome | 13 | 2021 | 65017 | 0.070 |
Why?
|
Blood Sedimentation | 1 | 2008 | 234 | 0.070 |
Why?
|
Vincristine | 2 | 2015 | 1039 | 0.070 |
Why?
|
Photons | 2 | 2011 | 581 | 0.070 |
Why?
|
Prednisone | 3 | 2012 | 1565 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2532 | 0.060 |
Why?
|
Cyclophosphamide | 3 | 2015 | 2221 | 0.060 |
Why?
|
Organizational Case Studies | 1 | 2006 | 301 | 0.060 |
Why?
|
Radiotherapy | 3 | 2011 | 1504 | 0.060 |
Why?
|
Abdomen | 2 | 2024 | 1130 | 0.060 |
Why?
|
Carcinoma | 1 | 2016 | 2331 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 6 | 2018 | 20509 | 0.060 |
Why?
|
Back Pain | 2 | 2011 | 543 | 0.060 |
Why?
|
Spinal Fractures | 1 | 2011 | 702 | 0.060 |
Why?
|
Radiography | 3 | 2011 | 6965 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2015 | 1791 | 0.060 |
Why?
|
Radiotherapy, High-Energy | 1 | 2004 | 228 | 0.050 |
Why?
|
Survival Rate | 2 | 2018 | 12808 | 0.050 |
Why?
|
Pediatrics | 1 | 2018 | 3586 | 0.050 |
Why?
|
Protons | 3 | 2014 | 1114 | 0.050 |
Why?
|
Mastitis, Bovine | 1 | 2002 | 10 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5649 | 0.050 |
Why?
|
Switzerland | 1 | 2023 | 323 | 0.050 |
Why?
|
Phenylbutyrates | 1 | 2002 | 72 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3529 | 0.050 |
Why?
|
Neoplasm, Residual | 2 | 2021 | 1007 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2018 | 39261 | 0.050 |
Why?
|
Hospitals, General | 1 | 2006 | 795 | 0.050 |
Why?
|
Leukopenia | 1 | 2002 | 211 | 0.050 |
Why?
|
Recurrence | 1 | 2013 | 8482 | 0.050 |
Why?
|
Uremia | 1 | 2002 | 201 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2024 | 80372 | 0.050 |
Why?
|
Streptococcus agalactiae | 1 | 2002 | 337 | 0.040 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 3 | 2015 | 1660 | 0.040 |
Why?
|
Head and Neck Neoplasms | 1 | 2014 | 2882 | 0.040 |
Why?
|
Fetal Hemoglobin | 1 | 2002 | 342 | 0.040 |
Why?
|
Liver | 1 | 2015 | 7509 | 0.040 |
Why?
|
Mutation | 2 | 2021 | 29932 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 979 | 0.040 |
Why?
|
Bone Marrow Examination | 1 | 2019 | 155 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2002 | 15697 | 0.040 |
Why?
|
Milk | 1 | 2002 | 443 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2007 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2023 | 604 | 0.040 |
Why?
|
Leukemia, Myeloid | 1 | 2002 | 695 | 0.040 |
Why?
|
Serum Albumin | 1 | 2002 | 674 | 0.040 |
Why?
|
Abdominal Pain | 2 | 2016 | 1063 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2023 | 805 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2018 | 36290 | 0.040 |
Why?
|
Leg | 1 | 2003 | 1090 | 0.040 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2003 | 494 | 0.040 |
Why?
|
Ultrasonography | 2 | 2024 | 5961 | 0.040 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2010 | 2276 | 0.040 |
Why?
|
Streptococcal Infections | 1 | 2002 | 617 | 0.040 |
Why?
|
Vinblastine | 2 | 2012 | 487 | 0.040 |
Why?
|
Prognosis | 4 | 2023 | 29658 | 0.040 |
Why?
|
Tumor Burden | 2 | 2015 | 1895 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1456 | 0.040 |
Why?
|
Massachusetts | 2 | 2011 | 8803 | 0.040 |
Why?
|
Young Adult | 6 | 2021 | 58741 | 0.040 |
Why?
|
Chromosome Disorders | 1 | 2000 | 499 | 0.030 |
Why?
|
Pallor | 1 | 2016 | 5 | 0.030 |
Why?
|
Age Factors | 3 | 2018 | 18416 | 0.030 |
Why?
|
Disease Progression | 3 | 2021 | 13502 | 0.030 |
Why?
|
Cholestasis | 1 | 2019 | 377 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 1998 | 343 | 0.030 |
Why?
|
Adult | 7 | 2019 | 219994 | 0.030 |
Why?
|
Cyclosporine | 1 | 1998 | 777 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2000 | 1600 | 0.030 |
Why?
|
Topotecan | 1 | 2015 | 132 | 0.030 |
Why?
|
Bacteremia | 1 | 2002 | 980 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2008 | 3598 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2000 | 1122 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2019 | 733 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2002 | 15289 | 0.030 |
Why?
|
Anemia, Sickle Cell | 1 | 2002 | 1056 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2015 | 524 | 0.030 |
Why?
|
Ultrasonography, Mammary | 1 | 2016 | 239 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 2693 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 1998 | 664 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3301 | 0.030 |
Why?
|
Fatal Outcome | 1 | 1998 | 1832 | 0.030 |
Why?
|
Etoposide | 1 | 2015 | 630 | 0.030 |
Why?
|
Spleen | 1 | 2019 | 2298 | 0.030 |
Why?
|
Neoplasm Staging | 2 | 2012 | 11152 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2000 | 1764 | 0.030 |
Why?
|
Colon, Sigmoid | 1 | 2013 | 124 | 0.030 |
Why?
|
Brain | 3 | 2015 | 26951 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2021 | 1958 | 0.030 |
Why?
|
Mesentery | 1 | 2013 | 202 | 0.030 |
Why?
|
Methotrexate | 2 | 2012 | 1719 | 0.030 |
Why?
|
Regression Analysis | 1 | 2002 | 6360 | 0.020 |
Why?
|
Syndrome | 1 | 1998 | 3280 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2019 | 2414 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3143 | 0.020 |
Why?
|
Blood Transfusion | 1 | 1998 | 1328 | 0.020 |
Why?
|
Prospective Studies | 4 | 2021 | 54303 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6465 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4541 | 0.020 |
Why?
|
Rhabdomyosarcoma, Alveolar | 1 | 2011 | 42 | 0.020 |
Why?
|
Acute Disease | 1 | 2002 | 7269 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3361 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2560 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2725 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2002 | 1895 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2013 | 532 | 0.020 |
Why?
|
Risk | 1 | 2002 | 9631 | 0.020 |
Why?
|
Telomere | 1 | 2015 | 933 | 0.020 |
Why?
|
Risk Factors | 3 | 2021 | 74359 | 0.020 |
Why?
|
Survival Analysis | 1 | 2002 | 10182 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 1998 | 1869 | 0.020 |
Why?
|
Odds Ratio | 1 | 2002 | 9716 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2008 | 7408 | 0.020 |
Why?
|
Estrogens | 1 | 2016 | 1520 | 0.020 |
Why?
|
Nausea | 1 | 2012 | 678 | 0.020 |
Why?
|
Bradycardia | 1 | 2011 | 299 | 0.020 |
Why?
|
Radiometry | 1 | 2014 | 813 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5870 | 0.020 |
Why?
|
Vomiting | 1 | 2012 | 650 | 0.020 |
Why?
|
Cisplatin | 1 | 2015 | 1644 | 0.020 |
Why?
|
Growth Plate | 1 | 2010 | 274 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2648 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21025 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1636 | 0.020 |
Why?
|
Femur Head | 1 | 2010 | 297 | 0.020 |
Why?
|
Pulmonary Blastoma | 1 | 2008 | 41 | 0.020 |
Why?
|
Pelvic Bones | 1 | 2010 | 270 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12159 | 0.020 |
Why?
|
Celiac Disease | 1 | 2016 | 822 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4578 | 0.020 |
Why?
|
Pain | 1 | 2003 | 5066 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2015 | 1183 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11345 | 0.020 |
Why?
|
Cohort Studies | 2 | 2018 | 41335 | 0.020 |
Why?
|
Testis | 1 | 2010 | 794 | 0.020 |
Why?
|
Bone Diseases, Metabolic | 1 | 2011 | 409 | 0.020 |
Why?
|
Neutropenia | 1 | 2012 | 884 | 0.020 |
Why?
|
Peritoneal Neoplasms | 1 | 2013 | 707 | 0.020 |
Why?
|
Anemia | 1 | 2016 | 1511 | 0.020 |
Why?
|
Appendicitis | 1 | 2013 | 674 | 0.020 |
Why?
|
Decision Making | 1 | 2000 | 3925 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3610 | 0.020 |
Why?
|
Neuralgia | 1 | 2012 | 600 | 0.020 |
Why?
|
Time Factors | 3 | 2021 | 40165 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 1998 | 4166 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5794 | 0.020 |
Why?
|
Testosterone | 1 | 2016 | 2470 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2013 | 2943 | 0.020 |
Why?
|
Procarbazine | 1 | 2004 | 172 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3568 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6544 | 0.010 |
Why?
|
Parents | 1 | 2018 | 3549 | 0.010 |
Why?
|
Thoracic Surgical Procedures | 1 | 2008 | 348 | 0.010 |
Why?
|
Urinary Bladder | 1 | 2010 | 1166 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3839 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13262 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1266 | 0.010 |
Why?
|
Risk Assessment | 2 | 2021 | 24123 | 0.010 |
Why?
|
Immunotherapy | 1 | 2019 | 4642 | 0.010 |
Why?
|
Aged | 2 | 2008 | 169152 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2012 | 4902 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2016 | 2421 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2013 | 2526 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2015 | 3455 | 0.010 |
Why?
|
Middle Aged | 2 | 2008 | 220352 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12531 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2000 | 26181 | 0.010 |
Why?
|
United States | 2 | 2021 | 72461 | 0.010 |
Why?
|
Defective Viruses | 1 | 1978 | 89 | 0.010 |
Why?
|
DNA, Circular | 1 | 1978 | 97 | 0.010 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2002 | 1006 | 0.010 |
Why?
|
DNA Primers | 1 | 2002 | 2819 | 0.010 |
Why?
|
DNA, Mitochondrial | 1 | 2002 | 858 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 13308 | 0.010 |
Why?
|
Cattle | 1 | 2002 | 3847 | 0.010 |
Why?
|
Pneumonia | 1 | 2008 | 2131 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13630 | 0.010 |
Why?
|
Simplexvirus | 1 | 1978 | 803 | 0.010 |
Why?
|
Administration, Oral | 1 | 2002 | 4035 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11071 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8986 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6068 | 0.010 |
Why?
|
Patient Compliance | 1 | 2002 | 2688 | 0.010 |
Why?
|
DNA, Viral | 1 | 1978 | 2194 | 0.010 |
Why?
|
Base Sequence | 1 | 2002 | 12446 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10827 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14660 | 0.000 |
Why?
|
Molecular Weight | 1 | 1978 | 2186 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1978 | 2558 | 0.000 |
Why?
|
Virus Replication | 1 | 1978 | 2432 | 0.000 |
Why?
|
Animals | 1 | 2002 | 167963 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1978 | 2907 | 0.000 |
Why?
|
Cell Line | 1 | 1978 | 15620 | 0.000 |
Why?
|